What is oral Wegovy?
Oral Wegovy is a once-daily tablet containing 25 mg of semaglutide — the same active ingredient as injectable Wegovy and Ozempic, formulated for absorption through the stomach lining. Novo Nordisk launched it in the US in January 2026 after FDA approval in late 2025.
It joins Foundayo (orforglipron) as the second oral GLP-1 on the US market for chronic weight management. Unlike Foundayo, oral Wegovy retains the fasting/water protocol that Rybelsus introduced — it's the trade-off for using the same peptide molecule as the injection.
Mechanism of action
Oral Wegovy vs Rybelsus: both are oral semaglutide
This is the most-confused point. Both products are oral semaglutide manufactured by Novo Nordisk. The differences:
| Rybelsus | Oral Wegovy | |
|---|---|---|
| Dose | 7 mg or 14 mg | 25 mg |
| FDA indication | Type 2 diabetes | Chronic weight management |
| Coverage | Diabetes plans usually cover | Obesity plans + Medicare Bridge |
| Typical weight loss | ~6-8% (off-label use) | ~13.6% |
| Fasting protocol | Yes | Yes |
If you're currently on Rybelsus for weight loss and tolerating it, your prescriber may switch you to oral Wegovy 25 mg for stronger efficacy (and easier insurance coverage if your plan covers obesity drugs but not off-label Rybelsus).
How to take oral Wegovy
The fasting protocol is non-negotiable for absorption:
- 1Take first thing in the morning on an empty stomach.
- 2Swallow with no more than 4 oz (½ cup) of plain water. No coffee, juice, or sparkling water.
- 3Wait at least 30 minutes before consuming food, other drinks, or other medications.
- 4Swallow whole — do not split, crush, or chew.
Dose escalation: start at 3 mg daily for 4 weeks → 7 mg for 4 weeks → 14 mg for 4 weeks → 25 mg maintenance. Slower titration than injectable Wegovy because GI side effects are slightly more common with oral.
Efficacy: oral vs. injectable
The OASIS-4 phase 3 trial (n=667, 64 weeks) tested oral semaglutide 25 mg vs. placebo in adults with BMI ≥30 (or ≥27 with comorbidity). Headline results:
| Arm | Mean weight change | ≥10% loss | ≥15% loss |
|---|---|---|---|
| Oral semaglutide 25 mg | −13.6% | 59% | 39% |
| Placebo | −2.2% | 12% | 3% |
For context: injectable Wegovy 2.4 mg achieves ~14.9% loss; injectable Zepbound 15 mg achieves ~22.5%. Oral Wegovy is meaningfully behind Zepbound but on par with injectable Wegovy — at a much lower self-pay price ($149-299 vs. $1,350 list).
Weight-loss trajectory · OASIS-4 (25 mg oral)
Mean change in body weight over the 64-week trial.
Cost: how to get oral Wegovy under $300/month
List price for oral Wegovy is approximately $1,000/month. Access paths:
- Hims & Hers (telehealth): $149-299/month for self-pay patients via their oral semaglutide program. Confirmed Novo Nordisk partnership March 2026.
- Commercial insurance: $25-100/month copay if covered; requires BMI ≥30 (or ≥27 + comorbidity) + prior auth.
- Medicare GLP-1 Bridge: $50/month copay effective July 1, 2026.
- NovoCare savings card: commercially insured can get list price reduced to ~$499/month.
Monthly cost in the US
What Oral Wegovy costs by payment path
Real out-of-pocket varies. Cash list price is what the pharmacy bills without insurance. Commercial copay assumes a tier-3 specialty plan. Savings-card numbers come from manufacturer programs.
$1,000/mo
What you pay at the pharmacy with no insurance, no coupons.
$25–$200/mo
Typical tier-3 specialty copay if your plan covers GLP-1s for your indication. Coverage is uneven.
$0–$225/mo
Commercially insured (not Medicare/Medicaid) — up to $225/mo off, max $3,500/yr. Same program as injectable Wegovy.
Prices verified against manufacturer pages and FDB pharmacy data. Last reviewed: 2026. Affordability programs change; verify eligibility directly with the manufacturer before assuming you qualify.
Where to buy
Oral Wegovy (semaglutide 25mg) across providers
Prices verified May 2026 · Sponsored links — disclosed below
Hims & Hers
Best priceBest for: self-pay, fastest setup
Start with Hims$149/mo
Starter tier; ramps to $299/mo at maintenance
Ro
Best for: insurance navigation
Start with Ro$299/mo
Includes consult + PA submission
NovoCare savings
Best for: commercially insured
Apply for savings card$499/mo
Manufacturer card (commercial insurance required)
Retail (CVS/Walgreens)
Best for: price benchmarking
Compare pharmacies$1,005/mo
Full list price, no discounts
Editorially independent. Provider rankings unaffected by commission.
Affiliate disclosure
What patients reported on Oral Wegovy
Patient-reported outcomes from the OASIS-4 PRO substudy substudy, plus the Drugs.com community satisfaction rating. These are aggregate signals, not individual testimonials.
Lost ≥10% weight
64%
Share of 25 mg participants reaching the ≥10% threshold
Lost ≥15% weight
40%
Share of 25 mg participants reaching the ≥15% threshold
Comparable to injectable
~92%
13.6% oral vs 14.9% injectable — equivalence within ~1 pct point
Trial discontinuation
13%
Slightly higher than injectable; fasting amplifies early nausea
Drugs.com community rating from 86 verified user reviews. View on Drugs.com →
Source: OASIS-4 PRO substudy (Lancet 2024) + Drugs.com community rating accessed 2026.
Who should consider oral Wegovy
Good fit for:
- Patients who want semaglutide-grade efficacy without needles
- Self-pay patients seeking lowest entry cost ($149/mo via Hims)
- Existing Rybelsus users needing higher dose for weight loss
- Morning routine people who can commit to 30-min fasting window
Probably not ideal if:
- You eat breakfast immediately on waking (fasting window won't fit)
- You take other morning medications you can't reschedule
- You want maximum weight loss — Zepbound injectable is more effective
How to get a prescription
Three pathways:
- 1Hims & Hers — the fastest path. Online intake, physician review, ship to home. See Hims review.
- 2Other telehealth providers — Ro, Sequence, MEDVi adding coverage through Q2-Q3 2026. Compare all.
- 3Your existing PCP or endocrinologist — in-person eligibility + insurance navigation.
Frequently asked questions
- How is oral Wegovy different from Rybelsus?
- Both are oral semaglutide, but oral Wegovy is the higher 25 mg daily dose approved for chronic weight management. Rybelsus is 7 mg or 14 mg approved only for type 2 diabetes (off-label for weight loss). Same molecule, different doses, different indications.
- How much weight can I lose on oral Wegovy?
- In the OASIS-4 trial, participants on oral semaglutide 25 mg lost an average of 13.6% of body weight at 64 weeks vs. 2.2% on placebo — comparable to injectable Wegovy (~14.9%) and meaningfully more than Foundayo (~11.2%).
- Do I need to fast before taking oral Wegovy?
- Yes. Take on an empty stomach in the morning with no more than 4 oz of plain water, then wait at least 30 minutes before food, other drinks, or other medications. This is the same protocol as Rybelsus and is required for the drug to absorb properly.
- How much does oral Wegovy cost?
- List price is ~$1,000/month. Hims & Hers offers oral Wegovy at $149-299/month for self-pay patients via their telehealth program (confirmed March 2026 partnership with Novo Nordisk). Commercial insurance copay varies; Medicare Bridge $50/mo from July 1.
- Can I switch from injectable Wegovy to oral Wegovy?
- Yes — same molecule. Discuss timing with your prescriber: typically take the last injection, wait 7 days, then start the oral dose at 25 mg daily (no titration needed if you were already at the highest injectable dose).
- Is oral Wegovy as effective as injectable Wegovy?
- Nearly. OASIS-4 showed ~13.6% loss on oral 25 mg vs. ~14.9% on injectable 2.4 mg over 64 weeks. The small difference is clinically minor; choose based on preference for daily pill (with fasting) vs. weekly injection (no fasting).
Disclosure: Glpverdict is affiliate-funded but editorially independent. Provider links may be sponsored; this does not affect editorial rankings or clinical accuracy. Reviewed by Jane Novak, MD, MPH.
